Medicare Enrolled

Dr. Philip Getson, D.O.

Family Medicine · Marlton, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
100 BRICK RD, Marlton, NJ 08053
8569837246
In practice since 2007 (19 years)
NPI: 1083749501 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Getson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Getson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Getson

Dr. Philip Getson is a family medicine specialist in Marlton, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Getson performed 13,177 Medicare services across 759 unique beneficiaries.

Between the years covered by Open Payments, Dr. Getson received a total of $1,184 from 11 pharmaceutical and/or device companies across 89 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Getson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 0% volume in NJ $1,184 industry payments

Medicare Practice Summary

Medicare Utilization ↗
13,177
Medicare services
Top 0% in NJ for family medicine
759
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~694 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
1,971 $13 $57
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
1,616 $25 $55
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
1,615 $17 $101
Anti-nausea injection (ondansetron/Zofran) 1,429 $0 $6
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
985 $11 $75
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
954 $69 $125
Midazolam injection, per 1 mg
Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments.
684 $0 $6
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
539 $116 $250
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
538 $54 $203
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
538 $33 $94
Routine 12-lead electrocardiogram (ECG)
A test that records the electrical activity of the heart using at least 12 leads to produce a tracing.
536 $6 $75
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
510 $2 $92
Intravenous hydration infusion, 31-60 minutes
Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes.
329 $29 $125
Normal saline infusion, 500 ml
Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution.
286 $1 $11
Injection, lorazepam, 2 mg 246 $1 $12
Diazepam injection, up to 5 mg
A medication injection containing diazepam with a dosage of up to 5 milligrams.
155 $4 $5
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
125 $1 $6
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
121 $0 $4
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
25.1% high complexity
52.3% medium
22.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,184
Total received (2018-2024)
Avg $169/year across 7 years
Top 29% in NJ for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
11
Companies
89
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,184 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$173
2023
$205
2022
$329
2021
$250
2020
$138
2019
$27
2018
$61

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$93
Collegium Pharmaceutical, Inc.
$81
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$410
Collegium Pharmaceutical, Inc.
$385
Almatica Pharma LLC
$67
Supernus Pharmaceuticals, Inc.
$65
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$52
Bio Products Laboratory USA, Inc.
$45
IBSA Pharma Inc.
$42
BioCryst US Sales Co., LLC
$42
BioDelivery Sciences International, Inc.
$39
Daiichi Sankyo Inc.
$24
Scilex Pharmaceuticals Inc.
$13
Top 3 companies account for 72.8% of all-time payments
Associated products mentioned in payments ›
BELBUCA · Belbuca · GRALISE · Gammaplex · LOREEV XR · Licart · Morphabond ER · OXTELLAR XR · Orladeyo · RELISTOR · TROKENDI XR · Tirosint · XIFAXAN · XTAMPZA · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a family medicine specialist in Marlton?
Compare family medicine physicians in the Marlton area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
1,813
Per 100K population
390.5
County median income
$105,271
Nearest hospital
WEISMAN CHILDRENS REHABILITATION HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Getson is a mixed practice specialist, with above-average Medicare volume (top 0% in NJ), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Getson experienced with intravenous injection of additional new drug or substance?
Based on Medicare claims data, Dr. Getson performed 1,971 intravenous injection of additional new drug or substance services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Getson receive payments from pharmaceutical companies?
Yes. Dr. Getson received a total of $1,184 from 11 companies across 89 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Getson's costs compare to other family medicine physicians in Marlton?
Dr. Getson's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Getson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →